| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | LHX2 ZBTB7A DEAF1 SOX21 ZBTB8B FOXB2 GATA4 SKOR1 SP5 GBX1 POU3F1 RUNX2 PHOX2B ZFX ZIC2 | 1.90e-06 | 1412 | 52 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | chromatin binding | LHX2 ARID1B TOX4 ASXL3 GATA4 CHD3 ASXL2 RUNX2 HCFC1 ZFX ZIC2 | 2.50e-06 | 739 | 52 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | LHX2 ZBTB7A DEAF1 SOX21 FOXB2 GATA4 SKOR1 SP5 GBX1 POU3F1 RUNX2 PHOX2B HCFC1 ZFX ZIC2 | 2.85e-06 | 1459 | 52 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | LHX2 ZBTB7A SOX21 FOXB2 GATA4 SKOR1 SP5 POU3F1 RUNX2 PHOX2B HCFC1 ZFX ZIC2 | 1.29e-05 | 1244 | 52 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | LHX2 ZBTB7A SOX21 FOXB2 GATA4 SKOR1 SP5 POU3F1 RUNX2 PHOX2B HCFC1 ZFX ZIC2 | 1.63e-05 | 1271 | 52 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.29e-05 | 167 | 52 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.89e-04 | 560 | 52 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 6.27e-04 | 566 | 52 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.35e-03 | 21 | 52 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.46e-03 | 86 | 52 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 2.41e-03 | 28 | 52 | 2 | GO:0005251 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZBTB7A DEAF1 SOX21 MAGED4 KMT5A GATA4 SKOR1 SP5 ID4 POU3F1 IRF2BPL CHD3 ASXL2 HCFC1 SAP30 | 3.79e-08 | 1053 | 53 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZBTB7A DEAF1 SOX21 MAGED4 KMT5A GATA4 SKOR1 SP5 ID4 POU3F1 IRF2BPL CHD3 ASXL2 RUNX2 HCFC1 SAP30 ZIC2 | 3.84e-08 | 1399 | 53 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ZBTB7A DEAF1 SOX21 MAGED4 KMT5A GATA4 SKOR1 SP5 ID4 POU3F1 IRF2BPL CHD3 ASXL2 RUNX2 HCFC1 SAP30 ZIC2 | 4.44e-08 | 1413 | 53 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | LHX2 DEAF1 SOX21 CDK13 ASXL3 GATA4 ID4 POU3F1 IRF2BPL ASXL2 RUNX2 SPAG8 PHOX2B HCFC1 ZFX ZIC2 | 2.27e-07 | 1390 | 53 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.67e-05 | 445 | 53 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 2.95e-05 | 482 | 53 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 1.08e-04 | 96 | 53 | 4 | GO:0035914 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 1.30e-04 | 306 | 53 | 6 | GO:0048863 | |
| GeneOntologyCellularComponent | chromatin | LHX2 ARID1B TOX4 DEAF1 SOX21 KMT5A ZBTB8B FOXB2 GATA4 SP5 GBX1 POU3F1 CHD3 RUNX2 PHOX2B HCFC1 SAP30 ZFX | 1.07e-08 | 1480 | 53 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ZBTB7A ARID1B UTP18 DEAF1 CDK13 ASXL3 GATA4 CHD3 ASXL2 RBM47 PRPF40A HCFC1 SAP30 | 2.92e-05 | 1377 | 53 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | PR-DUB complex | 3.77e-05 | 4 | 53 | 2 | GO:0035517 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 2.55e-05 | 263 | 47 | 7 | MP:0011099 | |
| Domain | HARE-HTH | 2.37e-05 | 3 | 53 | 2 | PF05066 | |
| Domain | ASXH | 2.37e-05 | 3 | 53 | 2 | PF13919 | |
| Domain | PHD_3 | 2.37e-05 | 3 | 53 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 2.37e-05 | 3 | 53 | 2 | IPR026905 | |
| Domain | ASX/ASX-like | 2.37e-05 | 3 | 53 | 2 | IPR024811 | |
| Domain | ASXH | 2.37e-05 | 3 | 53 | 2 | IPR028020 | |
| Domain | HB1/Asxl_HTH | 2.37e-05 | 3 | 53 | 2 | IPR007759 | |
| Domain | - | 5.10e-04 | 55 | 53 | 3 | 1.10.30.10 | |
| Domain | - | 5.12e-04 | 12 | 53 | 2 | 3.10.390.10 | |
| Domain | SAND_dom-like | 5.12e-04 | 12 | 53 | 2 | IPR010919 | |
| Domain | HMG_box_dom | 8.32e-04 | 65 | 53 | 3 | IPR009071 | |
| Domain | BTB | 1.69e-03 | 180 | 53 | 4 | SM00225 | |
| Domain | BTB/POZ_dom | 1.87e-03 | 185 | 53 | 4 | IPR000210 | |
| Domain | Homeobox_CS | 1.91e-03 | 186 | 53 | 4 | IPR017970 | |
| Domain | SKP1/BTB/POZ | 2.02e-03 | 189 | 53 | 4 | IPR011333 | |
| Domain | ZF_PHD_2 | 2.48e-03 | 95 | 53 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 2.56e-03 | 96 | 53 | 3 | PS01359 | |
| Domain | K_chnl_volt-dep_Kv | 2.65e-03 | 27 | 53 | 2 | IPR003968 | |
| Domain | VG_K_chnl | 3.94e-03 | 33 | 53 | 2 | IPR028325 | |
| Domain | Homeobox | 4.35e-03 | 234 | 53 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 4.48e-03 | 236 | 53 | 4 | PS00027 | |
| Domain | HOX | 4.55e-03 | 237 | 53 | 4 | SM00389 | |
| Domain | HOMEOBOX_2 | 4.69e-03 | 239 | 53 | 4 | PS50071 | |
| Domain | Homeobox_dom | 4.69e-03 | 239 | 53 | 4 | IPR001356 | |
| Domain | - | 8.44e-03 | 283 | 53 | 4 | 1.10.10.60 | |
| Domain | HMG_box | 9.93e-03 | 53 | 53 | 2 | PF00505 | |
| Domain | BTB_2 | 9.93e-03 | 53 | 53 | 2 | PF02214 | |
| Domain | T1-type_BTB | 9.93e-03 | 53 | 53 | 2 | IPR003131 | |
| Domain | HMG_BOX_2 | 1.03e-02 | 54 | 53 | 2 | PS50118 | |
| Domain | HMG | 1.03e-02 | 54 | 53 | 2 | SM00398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 5.67e-05 | 26 | 41 | 3 | M47923 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | LHX2 ZBTB7A TOX4 DEAF1 SOX21 GATA4 SKOR1 SP5 ID4 GBX1 POU3F1 RUNX2 PHOX2B ZFX ZIC2 | 3.95e-12 | 908 | 53 | 15 | 19274049 |
| Pubmed | LHX2 ZBTB7A ARID1B IRS4 DEAF1 FBRS GATA4 ID4 IRF2BPL CHD3 ASXL2 PRPF40A HCFC1 GADD45GIP1 | 1.96e-08 | 1429 | 53 | 14 | 35140242 | |
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 3.98e-07 | 10 | 53 | 3 | 32669118 | |
| Pubmed | JPH1 ZBTB7A ARID1B FBRS GATA4 CHD3 LTBP4 PRPF40A GADD45GIP1 SAP30 ZIC2 | 7.83e-07 | 1116 | 53 | 11 | 31753913 | |
| Pubmed | 1.15e-06 | 709 | 53 | 9 | 22988430 | ||
| Pubmed | 1.79e-06 | 57 | 53 | 4 | 35377797 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33812414 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30251205 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.36e-06 | 774 | 53 | 9 | 15302935 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.90e-06 | 410 | 53 | 7 | 26949251 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZBTB7A TOX4 UTP18 DEAF1 CDK13 CHD3 ASXL2 PRPF40A HCFC1 SAP30 ZFX | 3.28e-06 | 1294 | 53 | 11 | 30804502 |
| Pubmed | 3.35e-06 | 808 | 53 | 9 | 20412781 | ||
| Pubmed | 5.79e-06 | 23 | 53 | 3 | 23648511 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 16412590 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25835095 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 33751773 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 35247020 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 34374074 | ||
| Pubmed | The genomic landscape of core-binding factor acute myeloid leukemias. | 1.36e-05 | 4 | 53 | 2 | 27798625 | |
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 1.36e-05 | 4 | 53 | 2 | 34536441 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.56e-05 | 351 | 53 | 6 | 38297188 | |
| Pubmed | 1.61e-05 | 32 | 53 | 3 | 20610746 | ||
| Pubmed | The transcriptional control of trunk neural crest induction, survival, and delamination. | 1.93e-05 | 34 | 53 | 3 | 15691760 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 20628571 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 37551791 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.84e-05 | 583 | 53 | 7 | 29844126 | |
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 3.17e-05 | 40 | 53 | 3 | 27657450 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 24748658 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 4.48e-05 | 424 | 53 | 6 | 21731673 | |
| Pubmed | 4.74e-05 | 130 | 53 | 4 | 19386638 | ||
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 4.76e-05 | 7 | 53 | 2 | 26816381 | |
| Pubmed | Gonadotropin-releasing hormone-1 (GnRH-1) is involved in tooth maturation and biomineralization. | 4.76e-05 | 7 | 53 | 2 | 17948256 | |
| Pubmed | GATA4/FOG2 transcriptional complex regulates Lhx9 gene expression in murine heart development. | 4.76e-05 | 7 | 53 | 2 | 18577233 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 10594069 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 15262978 | ||
| Pubmed | 4.84e-05 | 46 | 53 | 3 | 20301533 | ||
| Pubmed | Identification of NPM-ALK interacting proteins by tandem mass spectrometry. | 5.17e-05 | 47 | 53 | 3 | 14968112 | |
| Pubmed | Transcriptional analysis of Gli3 mutants identifies Wnt target genes in the developing hippocampus. | 5.17e-05 | 47 | 53 | 3 | 22235033 | |
| Pubmed | 5.33e-05 | 134 | 53 | 4 | 19030180 | ||
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 7.84e-05 | 54 | 53 | 3 | 17151600 | |
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 8.15e-05 | 9 | 53 | 2 | 24932701 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 26416890 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 8.15e-05 | 9 | 53 | 2 | 23144817 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 37590135 | ||
| Pubmed | Role of GATA binding protein 4 (GATA4) in the regulation of tooth development via GNAI3. | 8.15e-05 | 9 | 53 | 2 | 28484278 | |
| Pubmed | Additional sex combs-like family genes are required for normal cardiovascular development. | 8.15e-05 | 9 | 53 | 2 | 24860998 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 15758185 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 15199122 | ||
| Pubmed | 8.75e-05 | 56 | 53 | 3 | 33053343 | ||
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 33996801 | ||
| Pubmed | The -KTS splice variant of WT1 is essential for ovarian determination in mice. | 1.02e-04 | 10 | 53 | 2 | 37917714 | |
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 1.02e-04 | 10 | 53 | 2 | 19815555 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.15e-04 | 313 | 53 | 5 | 38270169 | |
| Pubmed | 1.16e-04 | 730 | 53 | 7 | 34857952 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 18547559 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 23658227 | ||
| Pubmed | An ex vivo system to study cellular dynamics underlying mouse peri-implantation development. | 1.24e-04 | 11 | 53 | 2 | 35063082 | |
| Pubmed | Transcriptomic analysis of murine embryos lacking endogenous retinoic acid signaling. | 1.24e-04 | 11 | 53 | 2 | 23638021 | |
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 27292645 | ||
| Pubmed | RNA Pol II pausing facilitates phased pluripotency transitions by buffering transcription. | 1.49e-04 | 12 | 53 | 2 | 35981753 | |
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 38830761 | ||
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 9885572 | ||
| Pubmed | SoxE proteins are differentially required in mouse adrenal gland development. | 1.49e-04 | 12 | 53 | 2 | 18272785 | |
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 9247261 | ||
| Pubmed | 1.64e-04 | 772 | 53 | 7 | 16341674 | ||
| Pubmed | 1.67e-04 | 339 | 53 | 5 | 30415952 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.74e-04 | 182 | 53 | 4 | 32239614 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.75e-04 | 544 | 53 | 6 | 28473536 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 1.76e-04 | 13 | 53 | 2 | 22878500 | |
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 12091317 | ||
| Pubmed | LIM genes parcellate the embryonic amygdala and regulate its development. | 1.76e-04 | 13 | 53 | 2 | 15295034 | |
| Pubmed | Genome-wide association study of alcohol dependence implicates a region on chromosome 11. | 2.05e-04 | 14 | 53 | 2 | 20201924 | |
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 16452088 | ||
| Pubmed | 2.07e-04 | 1371 | 53 | 9 | 36244648 | ||
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 2.09e-04 | 75 | 53 | 3 | 37298722 | |
| Pubmed | 2.09e-04 | 191 | 53 | 4 | 24146773 | ||
| Pubmed | 2.26e-04 | 77 | 53 | 3 | 21525287 | ||
| Pubmed | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. | 2.36e-04 | 15 | 53 | 2 | 9804427 | |
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 20144603 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 17475798 | ||
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 17699610 | ||
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 11784859 | ||
| Pubmed | Specific glial populations regulate hippocampal morphogenesis. | 2.70e-04 | 16 | 53 | 2 | 19020026 | |
| Pubmed | Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. | 2.70e-04 | 16 | 53 | 2 | 20833366 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 22115758 | ||
| Pubmed | Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification. | 2.70e-04 | 16 | 53 | 2 | 10693795 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 20805357 | ||
| Pubmed | 2.74e-04 | 591 | 53 | 6 | 15231748 | ||
| Pubmed | 2.74e-04 | 205 | 53 | 4 | 20436479 | ||
| Pubmed | 2.82e-04 | 83 | 53 | 3 | 28794006 | ||
| Pubmed | Contribution of Hox genes to the diversity of the hindbrain sensory system. | 3.05e-04 | 17 | 53 | 2 | 14960494 | |
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 17694053 | ||
| Pubmed | 3.05e-04 | 17 | 53 | 2 | 12023301 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 3.09e-04 | 857 | 53 | 7 | 25609649 | |
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 27957530 | ||
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 9790534 | ||
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 10444591 | ||
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 23102580 | ||
| Pubmed | Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. | 3.43e-04 | 18 | 53 | 2 | 16790476 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.50e-04 | 398 | 53 | 5 | 35016035 | |
| Interaction | SMARCC2 interactions | 3.24e-05 | 353 | 52 | 7 | int:SMARCC2 | |
| Interaction | KDM6A interactions | 6.04e-05 | 162 | 52 | 5 | int:KDM6A | |
| Interaction | ARID1A interactions | 7.50e-05 | 276 | 52 | 6 | int:ARID1A | |
| Interaction | PCBP2 interactions | 9.48e-05 | 288 | 52 | 6 | int:PCBP2 | |
| Interaction | XRCC6 interactions | ZBTB7A TOX4 DEAF1 ASXL3 GATA4 CHD3 ASXL2 RUNX2 PRPF40A HCFC1 | 1.11e-04 | 928 | 52 | 10 | int:XRCC6 |
| Interaction | SMARCA1 interactions | 1.22e-04 | 188 | 52 | 5 | int:SMARCA1 | |
| Interaction | CSNK2A1 interactions | 1.42e-04 | 956 | 52 | 10 | int:CSNK2A1 | |
| Interaction | HDAC3 interactions | 1.49e-04 | 313 | 52 | 6 | int:HDAC3 | |
| Interaction | BACC1 interactions | 1.50e-04 | 104 | 52 | 4 | int:BACC1 | |
| Interaction | YY1 interactions | 1.57e-04 | 454 | 52 | 7 | int:YY1 | |
| Interaction | SMARCA4 interactions | 1.74e-04 | 462 | 52 | 7 | int:SMARCA4 | |
| Interaction | FEV interactions | 1.75e-04 | 203 | 52 | 5 | int:FEV | |
| Interaction | CBX4 interactions | 1.83e-04 | 205 | 52 | 5 | int:CBX4 | |
| Interaction | AR interactions | ZBTB7A ARID1B EPPK1 FBRS IRF2BPL CHD3 RUNX2 PRPF40A HCFC1 GADD45GIP1 | 1.91e-04 | 992 | 52 | 10 | int:AR |
| Interaction | LIN9 interactions | 1.92e-04 | 111 | 52 | 4 | int:LIN9 | |
| Interaction | RAN interactions | 2.07e-04 | 475 | 52 | 7 | int:RAN | |
| Cytoband | 6p22.3 | 1.31e-03 | 46 | 53 | 2 | 6p22.3 | |
| Coexpression | GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP | 8.50e-06 | 137 | 53 | 5 | M460 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.68e-07 | 210 | 52 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.10e-06 | 259 | 52 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 4.13e-06 | 98 | 52 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 4.35e-06 | 99 | 52 | 5 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_100 | 4.57e-06 | 100 | 52 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.25e-06 | 306 | 52 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 1.03e-05 | 118 | 52 | 5 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.79e-05 | 225 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | JPH1 LHX2 SOX21 PCLO ID4 POU3F1 IRF2BPL LTBP4 PRPF40A SAP30 ZIC2 | 2.09e-05 | 983 | 52 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 2.15e-05 | 986 | 52 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | JPH1 LHX2 IRS4 SOX21 KMT5A PCLO POU3F1 PRPF40A HCFC1 MAP3K4 ZIC2 | 2.31e-05 | 994 | 52 | 11 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.45e-05 | 493 | 52 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 2.52e-05 | 495 | 52 | 8 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.63e-05 | 498 | 52 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#1 | 2.91e-05 | 72 | 52 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.10e-05 | 248 | 52 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.75e-05 | 395 | 52 | 7 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.98e-05 | 279 | 52 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.30e-05 | 91 | 52 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.60e-05 | 298 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 9.20e-05 | 595 | 52 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 9.36e-05 | 97 | 52 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_100 | 9.74e-05 | 98 | 52 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_100 | 1.05e-04 | 100 | 52 | 4 | Facebase_RNAseq_e10.5_Olfactory Pit_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 1.05e-04 | 100 | 52 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 1.07e-04 | 973 | 52 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.45e-04 | 328 | 52 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 1.84e-04 | 491 | 52 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.37e-04 | 683 | 52 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 5.59e-04 | 979 | 52 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000 | 5.67e-04 | 981 | 52 | 9 | PCBC_DE_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromBlastocyst-derived-iPSC_top-relative-expression-ranked_1000 | 5.67e-04 | 981 | 52 | 9 | PCBC_DE_blastocyst_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 5.80e-04 | 984 | 52 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | e10.5_NeuroEpith_MedialEmin_top-relative-expression-ranked_100 | 6.20e-04 | 68 | 52 | 3 | Facebase_ST1_e10.5_NeuroEpith_MedialEmin_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 7.60e-04 | 814 | 52 | 8 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 9.54e-04 | 843 | 52 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 9.61e-04 | 844 | 52 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.01e-03 | 314 | 52 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.02e-03 | 654 | 52 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| Computational | Genes in the cancer module 123. | 1.51e-04 | 247 | 36 | 6 | MODULE_123 | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.98e-07 | 200 | 53 | 7 | 5917_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | 5.66e-06 | 193 | 53 | 6 | 4240_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.18e-06 | 196 | 53 | 6 | 4227_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 6.36e-06 | 197 | 53 | 6 | 6952_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 6.55e-06 | 198 | 53 | 6 | 3897_DN | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 6.55e-06 | 198 | 53 | 6 | 3900_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 6.74e-06 | 199 | 53 | 6 | 3777_UP | |
| Drug | A25618 | 6.91e-05 | 777 | 53 | 9 | CID000005562 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.96e-05 | 190 | 53 | 5 | 4340_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | 8.57e-05 | 193 | 53 | 5 | 4225_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 8.57e-05 | 193 | 53 | 5 | 4245_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 8.57e-05 | 193 | 53 | 5 | 5024_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.57e-05 | 193 | 53 | 5 | 5986_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 7406_DN | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 6553_UP | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 1707_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 4960_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 6712_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 3804_UP | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 4206_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 3745_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 1338_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 6396_DN | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; PC3; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 4195_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 7217_UP | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 4702_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 4336_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 2892_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 5394_UP | |
| Drug | Dirithromycin [62013-04-1]; Up 200; 4.8uM; HL60; HG-U133A | 9.67e-05 | 198 | 53 | 5 | 1712_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 7194_UP | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 4505_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 7473_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 5013_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 6652_UP | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 3324_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 4494_UP | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 6759_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 1648_DN | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.01e-04 | 200 | 53 | 5 | 3689_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 200 | 53 | 5 | 3276_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 200 | 53 | 5 | 5264_DN | |
| Disease | neuroblastoma (is_implicated_in) | 1.31e-04 | 10 | 51 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 3.91e-04 | 82 | 51 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 3.91e-04 | 82 | 51 | 3 | C0751111 | |
| Disease | Aura | 3.91e-04 | 82 | 51 | 3 | C0236018 | |
| Disease | Epilepsy | 8.98e-04 | 109 | 51 | 3 | C0014544 | |
| Disease | intellectual disability (is_implicated_in) | 1.24e-03 | 30 | 51 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | progressive supranuclear palsy | 1.32e-03 | 31 | 51 | 2 | MONDO_0019037 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.33e-03 | 125 | 51 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.33e-03 | 125 | 51 | 3 | C1879321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAAAAAAAARARARA | 6 | Q8NFD5 | |
| AAEAARAAEAAKAAE | 461 | Q14004 | |
| LVKAQRAAAAAAAAA | 666 | Q76L83 | |
| AQREAAAAAAVAAAA | 1066 | Q9C0F0 | |
| AAAAAAAAAAAAVIP | 491 | A0AV96 | |
| ELAVTAAAEAAAQAA | 1611 | P51610 | |
| AAAEAAAQAAATEEA | 1616 | P51610 | |
| NRAAVAVAVARADEA | 61 | Q9Y5R2 | |
| AAVAAAAAAAAAAAV | 221 | Q5VYV0 | |
| AASNRAARAAAAAAR | 111 | Q96JG8 | |
| AARAAAAAARTAFSQ | 116 | Q96JG8 | |
| VAAAAAAAAAAAAVV | 11 | Q9NQR1 | |
| AAAAAAAAVVAGQRR | 16 | Q9NQR1 | |
| AAEAERAAAAAAATA | 176 | Q5TGJ6 | |
| GRAAAVAAAVASAAA | 2966 | Q9UKN7 | |
| TAHARAKADAADQAA | 381 | Q9HDC5 | |
| RFLNQTAAAAADAEA | 441 | P38570 | |
| AAAAAAAAAVEQRSR | 156 | Q9H1B7 | |
| DAGAAIAAAEAAVQQ | 4911 | Q9Y6V0 | |
| DAAAAAAAAAAAERL | 26 | Q03052 | |
| FNHADVAAAAAAAAA | 181 | P50458 | |
| QAREAAAAVAAVAAG | 246 | Q96KK3 | |
| QRRRDAATAAAAAAA | 671 | Q8TE49 | |
| AAAAAAAARCKAAEA | 41 | P47928 | |
| AAAAVVAAAAAAAAA | 276 | O75400 | |
| AEAAAAAEAAAAAAE | 201 | Q8IZU1 | |
| SLAAAAAAAAAREAA | 116 | P43694 | |
| ERKEEAAAAAAAAAA | 306 | Q9HAH7 | |
| LAAAAAAAAATAARN | 121 | Q14549 | |
| AAAVAAAAAVAAAAA | 16 | O75398 | |
| AAAVAAAAAAAAAAV | 206 | Q12873 | |
| ANAVTEAARALAAAR | 66 | Q99501 | |
| AVARAEAAARAEAAA | 251 | Q8N2S1 | |
| ARAAALAAAVAQDPA | 201 | Q8TAE8 | |
| AAANAAAGAAENAFR | 331 | O14828 | |
| RGAAAAAAAALAAVV | 16 | O14654 | |
| AAAAAAAAAVAASRP | 1191 | Q9Y6R4 | |
| QEAAAAAAAAAAAAA | 71 | Q13950 | |
| KAVAAAVAAAAAAAA | 511 | P84550 | |
| AAAAAIAVAAAEEER | 56 | Q9Y5J1 | |
| RSALAAATAAAAAAA | 41 | Q99932 | |
| KAAAAAAAAAARVFF | 136 | Q9Y651 | |
| AAAAAAAAAALQRGL | 226 | Q6BEB4 | |
| AAAVAAVVAAAAAAA | 16 | O75446 | |
| TQEAAAAAAAAAARR | 2621 | P58107 | |
| RFDAREAAAAAAAAG | 171 | Q5U5Q3 | |
| RSSAAAAAAAAAGQI | 31 | O15270 | |
| VSENAGRAAAAAAAA | 86 | P55011 | |
| ALLAAAAAAAVRVCA | 36 | Q9NZV5 | |
| EDAAAAAAAAAVHEQ | 331 | P17010 | |
| QERAAAAAAAAAKNG | 156 | Q99453 | |
| RSVLQAAAAAAAAAS | 421 | O94842 | |
| AVAAAVAAVAAGDCN | 201 | O95365 | |
| AAAAAAAAAAVSAVH | 461 | O95409 | |
| EAAVAAAVAAAAAAA | 131 | Q8NAP8 | |
| SRAAAAAAVAAATAA | 36 | P22459 |